The council has developed a drug called QUOL2C that can relieve the side effects of chemotherapy and improve the general status of cancer patients. Trials to test the drug are ongoing at St John Medical College and Hospital in Bangalore, AIIMS, New Delhi and Tata Institute of Cancer, Mumbai. The council is collaborating with the Indian Council of Medical Research.

Dr. G S Lavekar, director general of CCRAS revealed that the council is also developing drugs for improving quality of life in HIV/AIDS patients. Furthermore the Council has also obtained 22 patents for ayurvedic drugs including one international patent. 

"After vigorous clinical trials, seven drugs developed by the council are in the market while seven others are on the pipeline. These include one for HIV/AIDS, cancer, psoriasis and disabled persons," Dr Lavekar said.

Other drugs that are on the anvil include AYUSH-Osto for osteoporosis and AYUSH-SL for filariasis. Ayush-Manas is another promising drug, which a medicine for mentally disabled people. Trials to test this drug are being undertaken at the Ram Monohar Lohia Hospital in New Delhi and NIMHANS, Bangalore.

The Council is also working on drugs to take care of lifestyle diseases like hypertension, stress, anxiety and fatigue.

Ayurveda is a system of traditional medicine native to India and literally means the science of life. The system believes that the body will be healthy if there is a balance of wind/spirit/air, phlegm, and bile. In recent years the practice of ayurveda has gained credence across the world.

This new initiative by the CCRAS to develop drugs to treat difficult conditions may popularize ayurveda even more.